Received an order for a product that will bring improvements to the healthcare industry
Scottsdale, Arizona, September 6, 2022 /PRNewswire/ — NeoLight announced that its Skylife Neonatal Phototherapy System has won an innovative technology contract from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company. The contract was awarded based on the recommendation of her Skylife neonatal phototherapy system by hospital experts, one of Vizient’s member-led councils. This represents unique qualities for Vizient members that may improve clinical care, patient safety or business operations. Medical institution.
The Skylife™ Neonatal Phototherapy System offers best-in-class spectral power that exceeds AAP guidelines.
- Reduction in bedside equipment
- reduce the workload of nurses
- Offers intermittent phototherapy to promote successful breastfeeding, kangaroo care, and skin-on-skin time with family.
The Skylife 3D Light Array™ covers 40% of the body surface with effective, uniform light and allows clinicians to choose from three levels of irradiance for optimal control of neonatal care.
“We are thrilled to receive this innovative technology contract from Vizient, which underscores the importance of best-in-class technology in our Skylife neonatal phototherapy system.” Aric Anderson, CEO of NeoLight. “Vizient serves a significant and large member base, and this agreement makes it even easier to access this extensive network. We are committed to working with Vizient member hospitals across the country on our mission to provide rapid relief, effectively lowering bilirubin levels and significantly reducing hospital costs.”
“Congratulations to NeoLight for winning the innovative technology contract,” he said. Kelly Flaherty, Senior Director of Contracting Processes at Vizient. “Our Member Council recommended the Sklife Neonatal Phototherapy System for this contract based on the efficiency it provides and the potential to make an incremental difference to healthcare.”
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated care delivery networks, and non-acute care providers. $130 billion in annual purchase volume. Through its Innovative Technology Program, Vizient collaborates with member-led councils and task forces to evaluate products for their potential to bring true innovation to healthcare. Vizient may award contracts outside of competitive bidding cycles to products it deems worthy of the Innovative Technology designation.
NeoLight is a medical device company that develops best-in-class technologies to treat preventable conditions in the neonatal care market. Empathy-driven solutions are frameworks centered around the ecosystem of doctors, nurses, mothers and infants. By cultivating an emotional connection, we provide not only treatment but also care. NeoLight advances neonatal care beyond the traditional hospital setting while also creating a strong at-home market for treating neonatal conditions at home. For more information, please visit www.theneolight.com and follow us. twitterLinkedIn, and Facebook.
contact: Kelly Johnson, [email protected]